VP of Operation of Asia Division
After receiving the doctorate degree in Molecular and Cellular Biology from National Tsing Hua University, Dr Lin has dedicated himself in the field of new drug development and cell therapy for over a decade, acquiring experience in R&D, management and business development. In addition to his specialty in MSC isolation, purification and expansion, Dr Lin also has extensive experience in peptide-drug conjugates (PDCs) development, preclinical pharmacological studies and early-stage clinical trial.
Dr Lin’s knowledge and expertise in cell therapy, quality management and Pre-IND provide perceptive insight to Invitrx Therapeutics, comprehensively optimizing the capacity and quality of our production.